Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
Avery A. Rizio, Menaka Bhor, Xiaochen Lin, et al.
Quality of Life Research (2020) Vol. 29, Iss. 6, pp. 1533-1547
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease
Kelly M. Harris, Liliana Preiss, Taniya Varughese, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2314070-e2314070
Open Access | Times Cited: 23
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States
George Goshua, Cecelia Calhoun, Satoko Ito, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 6, pp. 779-787
Open Access | Times Cited: 19
A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
Ahmar U. Zaidi, Alexander Glaros, Soyon Lee, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 33
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
Thomas Gentinetta, John D. Belcher, Valérie Brügger‐Verdon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 630-630
Open Access | Times Cited: 24
Redefining Ten; Reducing the Invisible Pain of Sickle Cell Disease
Nita Radhakrishnan
Indian Pediatrics (2025) Vol. 62, Iss. 1, pp. 11-12
Closed Access
Associations between disease severity, depression, health-related quality of life, and physical activity in adults with sickle cell disease
Adekola B. Ademoyegun, Mutiu Ademayowa Adeyemo, Babatunde Y. Adewuyi, et al.
Bulletin of Faculty of Physical Therapy (2025) Vol. 30, Iss. 1
Open Access
A Patient Centric Model for Vaso‐Occlusive Crises in Sickle Cell Disease—Outcomes of a Consensus Exercise Conducted Across Patients and Experts
Pooja Nandi, Robert Ellis, A V Deshpande
Clinical and Translational Science (2025) Vol. 18, Iss. 4
Open Access
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
Zachary K. Baldwin, Boshen Jiao, Anirban Basu, et al.
PharmacoEconomics - Open (2022) Vol. 6, Iss. 4, pp. 469-481
Open Access | Times Cited: 21
<p>Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review</p>
Soyon Lee, Diana K. Vania, Menaka Bhor, et al.
International Journal of General Medicine (2020) Vol. Volume 13, pp. 361-377
Open Access | Times Cited: 29
Burden of employment loss and absenteeism in adults and caregivers of children with sickle cell disease
Rachel D’Amico Gordon, Rina Li Welkie, Nives Quaye, et al.
Blood Advances (2024) Vol. 8, Iss. 5, pp. 1143-1150
Open Access | Times Cited: 3
The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis
George A. Morgan, Emily Back, Martin Besser, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance – the perspective of private and public payers
Nirmish Shah, Menaka Bhor, Dominick Latrémouille-Viau, et al.
Journal of Medical Economics (2020) Vol. 23, Iss. 11, pp. 1345-1355
Open Access | Times Cited: 23
Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective
Francesca Rodigari, Giorgia Brugnera, Raffaella Colombatti
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 13
Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource
Satoko Ito, Ankur Pandya, Ronald G. Hauser, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 570-576
Open Access | Times Cited: 2
An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
Marsha Treadwell, Swapandeep Mushiana, Sherif M. Badawy, et al.
Quality of Life Research (2022) Vol. 31, Iss. 9, pp. 2681-2694
Open Access | Times Cited: 8
Vaso-occlusive crisis pain intensity, frequency, and duration: which best correlates with health-related quality of life in adolescents and adults with sickle cell disease?
Donna K. McClish, Victoria Okhomina, Angela Pascale, et al.
Pain (2023) Vol. 165, Iss. 1, pp. 135-143
Closed Access | Times Cited: 4
Predictors of health-related quality of life in a large cohort of adult patients living with sickle cell disease in France: the DREPAtient study
Issifou Yaya, Adrien Pourageaud, Benjamin Derbez, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Health-related quality of life of children and adolescents with sickle cell disease: An evolutionary concept analysis
Suthan Pandarakutty, Judie Arulappan
Applied Nursing Research (2024) Vol. 80, pp. 151862-151862
Closed Access | Times Cited: 1
The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature
Boshen Jiao, Anirban Basu, Joshua A. Roth, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 11, pp. 1225-1241
Closed Access | Times Cited: 10
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
Ifeyinwa Osunkwo, John S James, Fuad El Rassi, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8, pp. 1055-1064
Open Access | Times Cited: 7
Nitric oxide and sickle cell disease—Is there a painful connection?
Lillian Hallmark, Luis E.F. Almeida, Sayuri Kamimura, et al.
Experimental Biology and Medicine (2020) Vol. 246, Iss. 3, pp. 332-341
Open Access | Times Cited: 9
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
Ferras Alashkar, Carmen Aramayo-Singelmann, Janine Böll, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1156-1156
Open Access | Times Cited: 6
A Quality Improvement Initiative to Decrease Time to Analgesia in Patients With Sickle Cell and Vaso-Occlusive Crisis: A Population With Disparities in Treatment
Tyler Arnold, R. Lane Coffee, Lynn Rosenberg, et al.
Cureus (2022)
Open Access | Times Cited: 6
Social determinants of health: the next frontier for improving care and outcomes in sickle cell disease
Jerlym S. Porter, Andrew M. Heitzer, Lori E. Crosby, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e571-e573
Closed Access | Times Cited: 3
Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
Kwaku Marfo, Yvonne Dei‐Adomakoh, Catherine Segbefia, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top